CHRISTCHURCH, New Zealand, Feb. 21, 2024 /PRNewswire/ — The Testing Consultancy (TTC), a global leader in software…
Day: February 21, 2024
Huawei Cloud Stack Takes Thailand by Storm with Cutting-Edge Features and Unmatched Security
BANGKOK, Feb. 21, 2024 /PRNewswire/ — Huawei Technologies (Thailand) Co., Ltd. held an event highlighting its…
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets
OSAKA, Japan, Feb. 21, 2024 /PRNewswire/ — Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo…
iKala Revolutionizes Influencer Marketing with KOL Radar Updates, Elevating Cross-Border Marketing Efficiency
KOL Radar introduces "Audience Authenticity Detection," "Competitor Analysis," and integrates "Korean Influencer Profiles" to enhance brand…
Call for Nominations: 2024 Enterprise Innovation Awards: Celebrating Eight Years of Digital Excellence in ASEAN
SINGAPORE, Feb. 21, 2024 /PRNewswire/ — ASEAN Innovation Business Platform (AIBP) proudly announces the call for…
Call for Nominations: 2024 Enterprise Innovation Awards: Celebrating Eight Years of Digital Excellence in ASEAN
SINGAPORE, Feb. 21, 2024 /PRNewswire/ — ASEAN Innovation Business Platform (AIBP) proudly announces the call for…
InnoCSR Secures New Investment from ADB Ventures, Garden Impact Fund, and Clarion Newlife Capital to Advance Green Non-Fired Brick Manufacturing in South Asia
KATHMANDU, Nepal and SEOUL, South Korea, Feb. 21, 2024 /PRNewswire/ — InnoCSR, at the forefront of…
Vectra AI and Gigamon Announce New OEM Partnership to Reduce Cybersecurity Risk for Large Enterprise Organizations
Vectra AI integrates Gigamon network intelligence and traffic analytics extending hybrid attack detection and response SINGAPORE,…
Everest Medicines’ Licensing Partner Venatorx Pharmaceuticals Announces Publication of Positive Results from Cefepime-Taniborbactam’s Phase 3 CERTAIN-1 Study in New England Journal of Medicine
—Cefepime-taniborbactam was superior to meropenem for the composite efficacy endpoint with composite efficacy sustained at late…